Previous close | 282.38 |
Open | 282.50 |
Bid | 284.32 x 100 |
Ask | 284.89 x 100 |
Day's range | 277.83 - 291.88 |
52-week range | 176.34 - 413.20 |
Volume | |
Avg. volume | 657,781 |
Market cap | 21.418B |
Beta (5Y monthly) | 1.64 |
PE ratio (TTM) | 46.95 |
EPS (TTM) | 6.06 |
Earnings date | 24 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 338.96 |
Inari Medical's (NARI) first-quarter results witness an increase in revenues with dismal bottom-line performance. Gross margins contract while the companies continue to incur operating losses.
Ecolab's (ECL) robust performance across the majority of its segments drives its first-quarter sales despite business challenges.
Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft first-quarter performance.